HJ SCIENCE-B 06132Hong Kong Stock Exchange

35.2005.83%( -2.180 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
HJ SCIENCE-B (06132) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
HJ Science Co., Ltd.
Market
HKEX Main Board
Listing Date
2026-06-23
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
Website
hj3h.com
ISIN
CNE100007PD2

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)15.22M106/112
Net Profit (Last FY)-158.41M71/125
ROE (Last FY)-40.18%96/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
姬建新 Executive Director
杨翔宇 Executive Director
吴振 Executive Director
张瑶 Executive Director
耿学莉 Non-Executive Director
王力源 Non-Executive Director
方圣石 Non-Executive Director
王志荣 Independent Non-Executive Director
姜和 Independent Non-Executive Director
林芳竹 Independent Non-Executive Director
刘哲 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-09-14.

About this page

This page shows HJ SCIENCE-B (06132) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.